India's second oldest cancer hospital (1954), founded by Muthulakshmi Reddy and led for decades by V. Shanta, and the home of India's first population cancer registry.
The Cancer Institute (WIA) was founded in 1954 in Adyar, Chennai, by Dr Muthulakshmi Reddy under the Women's Indian Association and built by Dr S. Krishnamurthi and Dr V. Shanta into a charitable comprehensive cancer centre that treats most patients free or at subsidised cost. It established India's first population-based cancer registry (Madras Metropolitan Tumour Registry, 1982), installed India's first cobalt teletherapy unit and later its first medical cyclotron in a cancer hospital, and pioneered Indian clinical trials in cervical cancer, paediatric leukaemia and oral cancer, including the landmark cluster-randomised trials of visual inspection screening for cervical cancer with IARC. It hosts a WHO collaborating centre for cancer registration and the Dr Krishnamurthi college of oncological sciences.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Cancer Institute (WIA), including child institutions. 76 works · 1,309 citations · 72% open access · 4% clinical trials · 0% reviews.
Ran the large Indian trials that showed a single round of HPV testing halves cervical cancer deaths and that visual oral examination cuts deaths in tobacco users, and led the study behind single-dose HPV vaccination.
The doctor who spent 66 years building Chennai's Cancer Institute into a hospital where most patients are treated free, and who set up India's first population cancer registry and paediatric oncology unit.
Shares National Cancer Registry Programme (ICMR-NINE, Bengaluru), National Cancer Grid of India, Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, International Agency for Research on Cancer (IARC / WHO), Brachytherapy.
Shares Cancer registries and population surveillance, Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination.
Shares Rengaswamy Sankaranarayanan, IARC India HPV vaccine dose study (one, two or three doses), International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination.
Shares Global oncology and access in low- and middle-income countries, Brachytherapy, HPV & HBV vaccination, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, Acute lymphoblastic leukaemia.